Avacta Group Plc (LON:AVCT)‘s stock had its “corporate” rating reissued by stock analysts at FinnCap in a research note issued to investors on Monday.

Separately, Numis Securities Ltd reissued a “buy” rating on shares of Avacta Group Plc in a report on Monday, August 1st.

Avacta Group Plc (LON:AVCT) opened at 88.05 on Monday. The firm’s market cap is GBX 59.12 million. The stock’s 50 day moving average price is GBX 96.44 and its 200 day moving average price is GBX 100.10. Avacta Group Plc has a 52 week low of GBX 83.02 and a 52 week high of GBX 140.50.

Avacta Group Plc Company Profile

Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.

Receive News & Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.